Wellgistics Health, Inc. operates as a holding company centered around pharmaceuticals and healthcare services. The company is headquartered in Tampa, Florida. The company went IPO on 2025-02-21. The company focuses on specialty medications and a community-based model offering home delivery services to patients. The company is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected to the Company’s health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, improve prescription price transparency, and provide additional concierge services. Its products include Kyzatrex and Semaglutide and Tirzepatide.
What are Wellgistics Health Inc's key financial statements?
According to the latest financial statement (Form-10K), Wellgistics Health Inc has a total asset of $0, Net 손실 of $0
What are the key financial ratios for WGRX?
Wellgistics Health Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.
How is Wellgistics Health Inc's revenue broken down by segment or geography?
Wellgistics Health Inc 주요 수익원은 Genie Retail Energy이며, 최신 수익 발표에서 수익은 403,340,000입니다. 지역별로는 United States이 Wellgistics Health Inc의 주요 시장이며, 수익은 424,481,000입니다.
Is Wellgistics Health Inc profitable?
no, according to the latest financial statements, Wellgistics Health Inc has a net 손실 of $0
Does Wellgistics Health Inc have any liabilities?
no, Wellgistics Health Inc has liability of 0
How many outstanding shares for Wellgistics Health Inc?
Wellgistics Health Inc has a total outstanding shares of 0